Table 1.
IMGAG | ICG | DMG | CFBOC | IHG | ||
---|---|---|---|---|---|---|
Sample size | Set 1 | 348 | 585 | 545 | 412 | 251 |
Set 2 | 1410 | |||||
Testing indication | Various | Cancer-related | Familial BC/OC | Familial BC/OC | Familial BC/OC | |
Considered PRS | BCAC 313 | BCAC 313 | BRIDGES 306 | BRIDGES 306 | BRIDGES 306 | |
BRIDGES 306 | ||||||
NGS approach | WGS |
Twist Custom Cancer Panel |
Twist Custom Panel | Agilent TruRisk v3 | Agilent TruRisk v3 | |
Reference | hg38 | hg19 | hg19 | hg19 | hg38 | |
Variant caller | Set 1 | DRAGEN v4.0.3 | freebayes v1.3.6 | DRAGEN v4.2.4 | freebayes v1.3.6 | CLC LightSpeed v23.0.2 |
Set 2 | freebayes v1.3.6 | GATK v4.2.6 HaplotypeCaller | GATK v4.4.0 HaplotypeCaller | GATK v4.3.2 HaplotypeCaller | GATK v4.2.6 HaplotypeCaller | |
Calling mode | Set 1 | Unforced | Forced | Forced | Forced | Unforced |
Set 2 | Forced | |||||
Quality filter | DP ≥ 15 | DP ≥ 20 | DP ≥ 20 | DP ≥ 30 | DP ≥ 10 |
Each center provided two data sets.
BC/OC breast/ovarian cancer, DP sequencing depth, PRS polygenic risk score.